Literature DB >> 9933101

Dendritic cells transfected with the nef genes of HIV-1 primary isolates specifically activate cytotoxic T lymphocytes from seropositive subjects.

D Chassin1, M Andrieu, W Cohen, B Culmann-Penciolelli, M Ostankovitch, D Hanau, J G Guillet.   

Abstract

The HIV-1 Nef protein down-modulates surface expression of MHC class I proteins. Primary infected T lymphocytes thus escape lysis by cytotoxic T lymphocytes (CTL). In contrast, during HIV-1 infection there are strong CTL responses to several HIV proteins, and there is mounting evidence that CTL are critical for controlling the virus. The present study was carried out to assess Nef protein-cell interaction as it occurs in naturally infected antigen-presenting cells. To evaluate the presentation of peptides derived from viral antigen to CTL, we transfected nef genes obtained from peripheral blood mononuclear cells of HIV-1-seropositive subjects into dendritic cells isolated from monocytes of healthy donors. We demonstrate that expression and subsequent processing of Nef by transfected dendritic cells did not alter the presentation of an immunodominant epitope of Nef to CTL of HIV+ subjects. However, mutations in nef gene sequences from primary isolates may abolish this presentation by a mechanism that probably interferes with protein processing.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9933101     DOI: 10.1002/(SICI)1521-4141(199901)29:01<196::AID-IMMU196>3.0.CO;2-4

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

Review 1.  HIV-1 and the hijacking of dendritic cells: a tug of war.

Authors:  Marie Larsson
Journal:  Springer Semin Immunopathol       Date:  2005-01

2.  Polyelectrolyte capsules-containing HIV-1 p24 and poly I:C modulate dendritic cells to stimulate HIV-1-specific immune responses.

Authors:  Winni De Haes; Stefaan De Koker; Charlotte Pollard; Derek Atkinson; Erika Vlieghe; Jessy Hoste; Joanna Rejman; Stefaan De Smedt; Johan Grooten; Guido Vanham; Ellen Van Gulck
Journal:  Mol Ther       Date:  2010-05-11       Impact factor: 11.454

3.  Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.

Authors:  Karina Yusim; Can Kesmir; Brian Gaschen; Marylyn M Addo; Marcus Altfeld; Søren Brunak; Alexandre Chigaev; Vincent Detours; Bette T Korber
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

4.  Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.

Authors:  Todd M Allen; Marcus Altfeld; Xu G Yu; Kristin M O'Sullivan; Mathias Lichterfeld; Sylvie Le Gall; Mina John; Bianca R Mothe; Paul K Lee; Elizabeth T Kalife; Daniel E Cohen; Kenneth A Freedberg; Daryld A Strick; Mary N Johnston; Alessandro Sette; Eric S Rosenberg; Simon A Mallal; Philip J R Goulder; Christian Brander; Bruce D Walker
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

5.  Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals.

Authors:  Ellen R Van Gulck; Guido Vanham; Leo Heyndrickx; Sandra Coppens; Katleen Vereecken; Derek Atkinson; Eric Florence; Ilse Kint; Zwi Nisan Berneman; Viggo Van Tendeloo
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

6.  Induction of protective immunity to Listeria monocytogenes with dendritic cells retrovirally transduced with a cytotoxic T lymphocyte epitope minigene.

Authors:  Yutaro Nakamura; Takafumi Suda; Toshi Nagata; Taiki Aoshi; Masato Uchijima; Atsushi Yoshida; Kingo Chida; Yukio Koide; Hirotoshi Nakamura
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

7.  Two human immunodeficiency virus vaccinal lipopeptides follow different cross-presentation pathways in human dendritic cells.

Authors:  Muriel Andrieu; Jean-François Desoutter; Estelle Loing; Jésintha Gaston; Daniel Hanau; Jean-Gérard Guillet; Anne Hosmalin
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

8.  Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences.

Authors:  Marcus Altfeld; Marylyn M Addo; Raj Shankarappa; Paul K Lee; Todd M Allen; Xu G Yu; Almas Rathod; Jason Harlow; Kristin O'Sullivan; Mary N Johnston; Philip J R Goulder; James I Mullins; Eric S Rosenberg; Christian Brander; Bette Korber; Bruce D Walker
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis.

Authors:  D Genovese; S Dettori; C Argentini; U Villano; P Chionne; M Angelico; M Rapicetta
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

10.  The C-terminal extension landscape of naturally presented HLA-I ligands.

Authors:  Philippe Guillaume; Sarah Picaud; Petra Baumgaertner; Nicole Montandon; Julien Schmidt; Daniel E Speiser; George Coukos; Michal Bassani-Sternberg; Panagis Filippakopoulos; David Gfeller
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.